Intravaginal DHEA has been found to improve vulvovaginal atrophy symptoms by acting on all three layers of the vagina. Oxytocin and phytoestrogens are being explored to provide treatment ...

While treatments for vulvovaginal atrophy have often focused on the ... the efficacy of new isoflavone vaginal gel was compared with the effectiveness of conjugated equine estrogen (CEE) and ...

Until recently, there were no treatments available to target the root cause. Today, we'll explore breakthroughs in treating geographic atrophy, including new medications and promising future ...

Treatment for breast cancer triggered painful vaginal symptoms, but I was too embarrassed to talk to my doctor about it. Here ...

Considering taking supplements to treat vaginal atrophy? Below is a list of common natural remedies used to treat or reduce the symptoms of vaginal atrophy. Follow the links to read common uses ...

Consult a medical professional for advice. Source: Focus Medica. Inflammation of the vagina due to thinning and shrinking of the tissues. This may cause pain during intercourse. Caused by lack of ...

They will perform a physical exam to diagnose you and recommend the proper treatment based on your symptoms and health history. This explains why menopause is the leading cause of vaginal atrophy ...

One of the most common sources of postmenopausal bleeding is vulvar or vaginal atrophy. Vulvar atrophy ... Hormonal medications or treatments, like hormonal contraceptives, can cause irregular ...

How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was to target the disease at the cellular and subcellular level. When people say Gleevec ...

And this knowledge has led to the development of potential new treatments. Over the last few years, scientists have been developing new drugs known as ‘biologics’. These drugs, delivered by ...

reversing retinal degeneration and providing hope for the many who do not respond to current treatments. Pre-clinical results for its leading drug NG004, show a new mode of action and NovaGo plans ...